Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases Gendelman, Howard Anatharam, Vellareddy Bronich, Tatiana Mallapragada, Surya Ghaisas, Shivani Jin, Huajun Kanthasamy, Anumantha Liu, Xinming McMillan, JoEllyn Mosley, R. Lee Narasimhan, Balagi Mallapragada, Surya
dc.contributor.department Biomedical Sciences
dc.contributor.department Chemical and Biological Engineering 2018-02-19T05:59:15.000 2020-06-30T01:09:34Z 2020-06-30T01:09:34Z Thu Jan 01 00:00:00 UTC 2015 2015-04-01
dc.description.abstract <p><p id="x-x-x-sp0005">Interest in nanoneuromedicine has grown rapidly due to the immediate need for improved biomarkers and therapies for psychiatric, developmental, traumatic, inflammatory, infectious and degenerative nervous system disorders. These, in whole or in part, are a significant societal burden due to growth in numbers of affected people and in disease severity. Lost productivity of the patient and his or her caregiver, and the emotional and financial burden cannot be overstated. The need for improved health care, treatment and diagnostics is immediate. A means to such an end is nanotechnology. Indeed, recent developments of health-care enabling nanotechnologies and nanomedicines range from biomarker discovery including neuroimaging to therapeutic applications for degenerative, inflammatory and infectious disorders of the nervous system. This review focuses on the current and future potential of the field to positively affect clinical outcomes. <h3 id="x-x-x-st1000">From the Clinical Editor</h3> <p id="x-x-x-sp1000">Many nervous system disorders remain unresolved clinical problems. In many cases, drug agents simply cannot cross the blood-brain barrier (BBB) into the nervous system. The advent of nanomedicines can enhance the delivery of biologically active molecules for targeted therapy and imaging. This review focused on the use of nanotechnology for degenerative, inflammatory, and infectious diseases in the nervous system.</p>
dc.description.comments <p>This article is published as Gendelman, Howard E., Vellareddy Anantharam, Tatiana Bronich, Shivani Ghaisas, Huajun Jin, Anumantha G. Kanthasamy, Xinming Liu et al. "Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases." Nanomedicine: Nanotechnology, Biology and Medicine 11, no. 3 (2015): 751-767. <a href="" target="_blank">10.1016/j.nano.2014.12.014</a>. Posted with permission.</p>
dc.format.mimetype application/pdf
dc.identifier archive/
dc.identifier.articleid 1309
dc.identifier.contextkey 11213417
dc.identifier.s3bucket isulib-bepress-aws-west
dc.identifier.submissionpath cbe_pubs/314
dc.language.iso en
dc.source.bitstream archive/|||Fri Jan 14 23:32:02 UTC 2022
dc.source.uri 10.1016/j.nano.2014.12.014
dc.subject.disciplines Biomedical Engineering and Bioengineering
dc.subject.disciplines Molecular, Cellular, and Tissue Engineering
dc.subject.disciplines Nanoscience and Nanotechnology
dc.subject.keywords Nanoeuromedicine
dc.subject.keywords Diagnostics
dc.subject.keywords Neurodegenerative disorders
dc.subject.keywords Nanotechnology
dc.subject.keywords Drug development
dc.title Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases
dc.type article
dc.type.genre article
dspace.entity.type Publication
relation.isAuthorOfPublication cf742fe7-cf8d-4bf5-98bd-00b8a45db967
relation.isOrgUnitOfPublication 184db3f2-d93f-4571-8ad7-07c8a9e6a5c9
relation.isOrgUnitOfPublication 86545861-382c-4c15-8c52-eb8e9afe6b75
Original bundle
Now showing 1 - 1 of 1
1.29 MB
Adobe Portable Document Format